ProtoKinetix Inc

PKTX:OTCQB
RT Quote | Exchange | USD
Last | 01/22/21 EST
0.107quote price arrow up+0.003 (+2.88%)
Volume
185,673
52 week range
0.05 - 0.22

...

Loading . . .

KEY STATS

  • Open0.1045
  • Day High0.107
  • Day Low0.1045
  • Prev Close0.104
  • 52 Week High0.22
  • 52 Week High Date03/16/20
  • 52 Week Low0.05
  • 52 Week Low Date07/10/20
  • Market Cap30.13M
  • Shares Out281.60M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.06
  • 1 Year % Change-10.16

RATIOS/PROFITABILITY

  • EPS (TTM)-0.03
  • P/E (TTM)-3.10
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-9.51M
  • ROE (MRQ)-2,445.20%
  • Revenue (MRQ)0.00M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest ProtoKinetix Inc News

There is no recent news for this security.

Latest PKTX News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
ProtoKinetix, Incorporated is a research and development-stage bio-technology company. The Company is focused on scientific medical research of Anti-Freeze Glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). AFGP is a compound produced by fish, insects, reptiles, bacteria and plants that enable survival in freezing temperatures. HealthCare Applications of AAGP fall into various categories, such as harvesting, storage and transplanting cells, tissues and organs, and...
Clarence Smith
President
Michael Guzzetta
Chief Financial Officer
Address
412 Mulberry St
Marietta, OH
45750-2016
United States